Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041544 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Juliana Bernardi Aggio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ-PR), Curitiba 81350-010, Brazil. Hauptthemen laut MEDLINE: Extracellular Vesicles, Chagas Disease, Trypanosoma cruzi, Antigens, Protozoan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Araucária, CNPq-Universal.
Abstract (Originalsprache)
Chagas disease remains a significant public health concern, with limited treatment options and an urgent need for novel preventive strategies. Extracellular vesicles (EVs) from Trypanosoma cruzi have been shown to modulate host immune responses, often favoring parasite persistence. In this study, we characterized EVs derived from the non-pathogenic trypanosomatids Trypanosoma rangeli and Phytomonas serpens and evaluated their potential as immunogens capable of inducing cross-protection against T. cruzi infection. Isolated EVs were characterized by Nanoparticle Tracking Analysis (NTA) and electron microscopy. A comparative proteomic analysis of EVs was performed using Mass Spectrometry-Based Proteomic Analysis (LC-MS/MS). The effects of EVs on immunomodulation and T. cruzi infection were assessed through in vitro and in vivo assays, using peripheral blood mononuclear cells (PBMCs) and BALB/c mice. The proteomic analysis identified shared proteins between the EVs of T. rangeli, P. serpens, and T. cruzi, including immunogenic candidates such as calpain-like cysteine peptidase and elongation factor 2. In vitro, pre-stimulation with the T. rangeli EVs reduced infection rates of the host cells by T. cruzi. In vivo, immunization with the EVs from T. rangeli and P. serpens led to a significant reduction in parasitemia in the BALB/c mice challenged with T. cruzi, though this did not translate into improved survival compared to controls. Interestingly, the EVs from T. cruzi also reduced parasitemia but did not confer protection against mortality. These findings suggest that while non-pathogenic trypanosomatid EVs exhibit potential immunogenic properties and can reduce parasitic load, their efficacy in preventing disease progression remains limited. Further research is needed to explore the mechanisms underlying these effects and to optimize EV-based strategies for protective immunity against Chagas disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ-PR), Curitiba 81350-010, Brazil.
- Laboratório de Biologia Celular e Protozoologia, Universidade Estadual de Ponta Grossa, Ponta Grossa 84030-900, Brazil.
- Grupo de Imunologia Molecular, Celular e Inteligência Artificial, Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ-PR), Curitiba 81350-010, Brazil.
- Laboratório de Imunopatologia Experimental, Departamento de Imunologia, Parasitologia e Patologia Geral, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina 86057-970, Brazil.
- Laboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina 86057-970, Brazil.
ORCID-Profile: Sueli Fumie Yamada-Ogatta, Phileno Pinge-Filho, Samuel Goldenberg, Iriane Eger, Pryscilla Fanini Wowk
Förderung
- National Council for Scientific and Technological Development
- Fundação Araucária
- CNPq-Universal
- Pesquisas sobre Doença de Chagas
- Fundação Araucária, PRONEX
- PROGRAMA PESQUISA BÁSICA E APLICADA
Zitieren
APA
Aggio, J. B., Vedam, V. V., Nisimura, L. M., da Silva, R. V., Lovo-Martins, M. I., Borges, B. S., Mörking, P. A., Batista, M., Marchini, F. K., Yamada-Ogatta, S. F., Pinge-Filho, P., Goldenberg, S., Eger, I., & Wowk, P. F. (2025). Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041544
Vancouver
Aggio JB, Vedam VV, Nisimura LM, da Silva RV, Lovo-Martins MI, Borges BS, et al. Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041544
BibTeX
@article{Aggio2025,
author = {Aggio, Juliana Bernardi and Vedam, Verônica Vitória and Nisimura, Líndice Mitie and da Silva, Rosiane Valeriano and Lovo-Martins, Maria Izabel and Borges, Beatriz Santana and Mörking, Patrícia Alves and Batista, Michel and Marchini, Fabricio Klerynton and Yamada-Ogatta, Sueli Fumie and Pinge-Filho, Phileno and Goldenberg, Samuel and Eger, Iriane and Wowk, Pryscilla Fanini},
title = {Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041544}
}
EUVIMED